Le Lézard
Classified in: Health
Subjects: LEG, SCZ, AVO

AARP Pennsylvania Convenes Discussion on Lower Prescription Drug Costs After Inflation Reduction Act Signed into Law


Senator Bob Casey joins AARP Discussion

HARRISBURG, Pa., Aug. 18, 2022 /PRNewswire/ -- Today, Pennsylvania Senator Bob Casey joined AARP Pennsylvania for a roundtable conversation highlighting how older Pennsylvanians will benefit from the Inflation Reduction Act of 2022, which was signed into law by President Biden earlier this week. 

"The Inflation Reduction Act is a game-changer for our seniors: it will make prescription drugs more affordable, cap annual out-of-pocket Medicare costs at $2,000 and will even cap the cost of insulin at $35 a month under Medicare Part D," said U.S. Sen. Bob Casey. "Today's discussion showed how much this new law will help Pennsylvania seniors who have struggled with high health care costs. Our work to lower costs for seniors and families continues, and I am proud to join AARP in that fight."

Gathered in AARP Pennsylvania's Harrisburg Office, State Director Bill Johnston-Walsh and Volunteer State President Joanne Grossi, along with Senator Casey and special guests Ginny Boynton of Mechanicsburg, Pennsylvania, and Susan Washinger, Community Organizer with PHAN (Pennsylvania Health Access Network) discussed how the bill will help lower prescription drug and health care costs for families across the state.

After decades of calling on Congress to make prescription drugs more affordable, AARP won the fight for Medicare to negotiate lower drug prices and help seniors save money on their medications. The historic new law will lower health care costs for seniors, including capping the cost of insulin at $35 per month for people who use Medicare Part D.

The bill will not only save money for millions of seniors, but it will also save lives by:

"This was a historic victory on behalf of AARP Pennsylvania's 1.8 million members, but the fight isn't over," said Joanne Grossi, AARP PA's Volunteer State President. "Big drug companies will spend millions trying to overturn the new law so they can keep charging Americans the highest prices in the world. AARP will keep fighting big drug companies' out-of-control prices. We won't back down and we are proud to have Senator Casey join us in this fight."

Contact: TJ Thiessen, [email protected], 202-374-8033

SOURCE AARP Pennsylvania


These press releases may also interest you

at 22:16
On May 10, 2024, the impactful international academic journal, Science Immunology, a sub-journal of Science, published a research paper titled "Single-cell analysis of anti-BCMA CAR T cell therapy in patients with central nervous system...

at 20:31
Fitness International, LLC opened a new Club Studio location in Kingwood, Texas. The new 40,000 square foot club features five innovative boutique fitness studios that were carefully curated to create a unique experience, along with recovery services...

at 19:35
Mirum Pharmaceuticals, Inc. today announced that on May 10, 2024, the Compensation Committee of Mirum's Board of Directors granted inducement awards consisting of non-qualified stock options to purchase 38,600 shares of common stock and 19,300...

at 19:00
Evolus, Inc. , a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today reported the grant of non-qualified stock options to purchase an aggregate of 10,990 shares of Evolus and an aggregate of 42,759...

at 18:36
Inhibrx, Inc. ("Inhibrx," or the "Company") today announced that in connection with the previously announced distribution by the Company of 92% of shares of common stock of its subsidiary Inhibrx Biosciences, Inc. ("SpinCo") to holders of shares of...

at 17:55
Asia Green Biotechnology Corp. ("Asia Green" or the "Company") announces that, further to its news releases dated April 17, 2024, April 26, 2024, and May 8, 2024, the Management Cease Trade Order ("MCTO") issued by the...



News published on and distributed by: